4//SEC Filing
Oliviero James F III 4
Accession 0001104659-24-129525
CIK 0001651407other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 9:32 PM ET
Size
5.0 KB
Accession
0001104659-24-129525
Insider Transaction Report
Form 4
Oliviero James F III
DirectorCEO, President and Director
Transactions
- Award
COMMON STOCK
2024-12-13+2,077,700→ 4,016,980 total
Footnotes (2)
- [F1]Represents previously-granted performance-based award that became vested upon achievement of a corporate milestone on December 13, 2024.
- [F2]Includes shares of restricted common stock, which vest over various time periods.
Documents
Issuer
Checkpoint Therapeutics, Inc.
CIK 0001651407
Entity typeother
Related Parties
1- filerCIK 0001434718
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 9:32 PM ET
- Size
- 5.0 KB